» Authors » Robert MacLaren

Robert MacLaren

Explore the profile of Robert MacLaren including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 117
Citations 1372
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Buckley M, Benanti G, Gilbert B, Meckel J, Dzierba A, MacLaren R
Pharmacotherapy . 2023 May; 43(8):795-803. PMID: 37199139
Study Objective: Severe coronavirus disease 2019 (COVID-19) increases the risk of thrombotic complications with unfractionated heparin (UFH) as a commonly used agent in managing venous thromboembolism (VTE). The optimal anticoagulation...
12.
MacLaren R
Curr Opin Clin Nutr Metab Care . 2023 Mar; 26(3):302-306. PMID: 36942898
Purpose Of Review: Enteral administration of medications to critically ill patients may be advantageous to other routes of administration. This review summarizes key considerations for the bedside clinician when medications...
13.
Stefanos S, Kiser T, MacLaren R, Mueller S, Reynolds P
Pharmacotherapy . 2023 Mar; 43(4):321-337. PMID: 36938775
Extravasation is the leakage of intravenous solutions into surrounding tissues, which can be influenced by drug properties, infusion techniques, and patient-related risk factors. Although peripheral administration of vesicants may increase...
14.
Buckley M, Benanti G, Meckel J, Tekle L, Gilbert B, Puebla Neira D, et al.
Pharmacotherapy . 2023 Feb; 43(3):196-204. PMID: 36759323
Study Objective: Thromboelastography (TEG) offers a more dynamic assessment of hemostasis over activated partial thromboplastin time (aPTT). However, the clinical utility of TEG in monitoring bivalirudin during extracorporeal membrane oxygenation...
15.
Reynolds P, Stefanos S, MacLaren R
Pharmacotherapy . 2023 Jan; 43(2):104-114. PMID: 36625778
Study Objective: Although fluid resuscitation is recommended by the Society of Critical Care Medicine Surviving Sepsis Campaign Guidelines, risks of volume overload persist.The objective of this systematic review is to...
16.
Buckley M, Kobic E, Yerondopoulos M, Sharif A, Benanti G, Meckel J, et al.
Ann Pharmacother . 2022 Dec; 57(9):1036-1043. PMID: 36575978
Background: The clinical utility of methicillin-resistant (MRSA) nasal screening appears promising for antimicrobial stewardship programs. However, a paucity of data remains on the diagnostic performance of culture-based MRSA screen in...
17.
Buckley M, Mendez A, Radosevich J, Agarwal S, MacLaren R
Am J Health Syst Pharm . 2022 Jul; 80(Suppl 1):S11-S22. PMID: 35877207
Purpose: Inhaled epoprostenol (iEPO) is a viable, temporizing option for acute respiratory distress syndrome (ARDS), although the optimal iEPO dosing strategy remains inconclusive. The purpose of this study was to...
18.
MacLaren R
Can J Hosp Pharm . 2022 Jul; 75(3):157-158. PMID: 35847471
No abstract available.
19.
MacLaren R
Can J Hosp Pharm . 2022 Jul; 75(3):155-156. PMID: 35847465
No abstract available.
20.
Bradley M, Kiser T, Mueller S, Reynolds P, MacLaren R
Ann Pharmacother . 2022 Jun; 57(2):175-183. PMID: 35713011
Background: Management of alcohol withdrawal syndrome (AWS) requires bedside assessments of symptom severity to guide therapies. Commonly used assessment tools are the Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar), the...